摘要
目的探究重组干扰素栓协同LEEP刀治疗高危人乳头瘤病毒感染宫颈上皮内瘤变患者的疗效。方法方便抽取2014年7月—2016年7月来该院就诊的高危人乳头瘤病毒感染宫颈上皮内瘤变Ⅰ~Ⅱ级患者38例并分为两组,观察组19例患者予以重组干扰素栓协同LEEP刀开展治疗,对照组19例患者予以LEEP刀治疗,并对比探究两组患者经过治疗以后的治疗成效、病毒水平等。结果比较表明了,观察组经过治疗以后的治疗成效94.74%、病毒转阴率73.68%、78.95%、89.47%都好于对照组的治疗成效68.42%、病毒转阴率36.84%、47.37%、57.89%(P<0.05)。结论重组干扰素栓协同LEEP刀治疗高危人乳头瘤病毒感染宫颈上皮内瘤变Ⅰ~Ⅱ级患者具有极为良好的成效,值得医学领域的大力推行及应用。
Objective To study the curative effect of recombinant interferon and LEEP knife in treatment of high-risk human papilloma virus cervical intraepithelial neoplasia. Methods Convenient selection 38 cases of patients with high-risk human papilloma virus cervical intraepithelial neoplasia Ⅰ~Ⅱ levels diagnosed in our hospital from July 2014 to July 2016 were selected and divided into two groups with 19 cases in each, the observation group were treated with recombinant interferon and LEEP knife, while the control group were treated with LEEP knife, and the treatment effect and virus level were compared between the two groups after treatment. Results The comparison showed that the treatment effective rate and virus negative rate after treatment in the observation group were better than those in the control group(94.74%, 73.68%,78.95%,89.47% vs 68.42%, 36.84%,47.37%,57.89%)(P<0.05). Conclusion The curative effect of recombinant interferon and LEEP knife in treatment of patients with Ⅰ-Ⅱ levels of high-risk human papilloma virus cervical intraepithelial neoplasia is good, which is worth great promotion and application in the medical field.
出处
《中外医疗》
2017年第24期47-49,共3页
China & Foreign Medical Treatment
